Rare diseases
Investigational molecules
Locations
50 Allee De Chaponval, 78590, France
Sqy Therapeutics is focused on clinical research in Duchenne muscular dystrophy, with interest in both paediatric and adult patients carrying a genetically confirmed diagnosis. Its work centres on a neuromuscular disease area marked by progressive muscle weakness and loss of function.
The sponsor’s research activity is directed toward the clinical understanding of Duchenne muscular dystrophy and related therapeutic needs in a specialised patient population.
Sqy Therapeutics runs clinical trials in conditions such as Duchenne muscular dystrophy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
